Researchers say work lays the foundation for a first-line, deployable antiviral platform that is virus agnostic and modular.

For a few dozen people in the world, the downside of living with a rare immune condition comes with a surprising ...

This isn't scientific disagreement. It's either staggering incompetence or willful misrepresentation,” writes infectious ...